Month: March 2023

BurgerFi to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023

Written by Customer Service on March 20, 2023. Posted in Public Companies.

FORT LAUDERDALE, Fla., March 20, 2023 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), will report financial results for the fourth quarter and fiscal year ended January 2, 2023 on Wednesday, March 22, 2023 before the market opens. Management will host a conference call at 8:30 a.m. Eastern time on the same day to discuss the results. The conference call will be broadcast live and available for replay on the Company’s Investor Relations website at ir.burgerfi.com. Participants can also access the call using the dial-in details below. Date: Wednesday, March 22, 2023Time: 8:30...

Galaxy Gaming Announces its Meeting of Shareholders For 2023

Written by Customer Service on March 20, 2023. Posted in Public Companies.

LAS VEGAS, March 20, 2023 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTCQB: GLXZ) (“Galaxy” or the “Company”), a developer and distributor of online and land-based casino table games and enhanced systems, announced today that its meeting of Shareholders will be held virtually on June 14, 2023, for shareholders of record as of April 17, 2023. The Notice of Shareholders Meeting will be provided to shareholders of record as of April 17, 2023, in accordance with applicable statutes and regulations. Forward-Looking Statements Certain statements in this release may constitute forward-looking statements, which involve a number of risks and uncertainties. Galaxy cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking...

AFC Gamma, Inc. Announces CFO Transition

Written by Customer Service on March 20, 2023. Posted in Public Companies.

WEST PALM BEACH, Fla., March 20, 2023 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (NASDAQ:AFCG) ( “AFC Gamma” or the “Company”) today announced that Brandon Hetzel, AFC Gamma’s current Executive Vice President, Controller, has been appointed to serve as the Company’s Chief Financial Officer and Treasurer. Mr. Hetzel’s appointment was approved by the Company’s Board of Directors on March 17, 2023. “Effective immediately, the Board has appointed Brandon Hetzel as Chief Financial Officer and Treasurer. We are very excited to have Brandon step into the role, as he has been integral to the Company’s success since he joined in September of 2020 and brings with him both detailed knowledge of our business and significant real estate experience, which will be valuable to AFC Gamma as it expands its investment strategy to include traditional commercial...

Globus Maritime Announces Filing of its 2022 Annual Report on Form 20–F

Written by Customer Service on March 20, 2023. Posted in Public Companies.

GLYFADA, Greece, March 20, 2023 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus,” the “Company,” “we,” or “our”), (NASDAQ: GLBS), a dry bulk shipping company, announced today that the Company’s annual report on Form 20-F that contains the Company’s audited financial statements for the fiscal year ended December 31, 2022 was filed today with the Securities and Exchange Commission, and may be found on the Company’s website at www.globusmaritime.gr under Investor Relations. Alternatively, shareholders may receive a hard copy of the 2022 Annual Report on Form 20-F, free of charge, by request to Globus’ Investor Relations Advisor at: Capital Link Inc.230 Park Avenue, Suite 1536New York, NY 10169 USATel: (+) 1 212 661 7566Email: globus@capitallink.com About Globus Maritime Limited Globus is an integrated dry bulk...

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

Written by Customer Service on March 20, 2023. Posted in Mergers And Acquisitions.

– CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC”– Cash and cash equivalents of approximately $34 million as of merger close expected to support operations into the second half of 2024– Phase 2b results in acute pancreatitis for lead product candidate Auxora™ expected in Q4 2023– CalciMedica to host Research and Development Event on April 27, 2023 LA JOLLA, Calif., March 20, 2023 (GLOBE NEWSWIRE) — CalciMedica Inc. (CalciMedica) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced the closing of its previously announced merger with Graybug Vision, Inc. CalciMedica’s stock will commence trading on March 21, 2023 on the...

Bluejay Diagnostics Reports 2022 Financial Results

Written by Customer Service on March 20, 2023. Posted in Earnings Releases And Operating Results.

ACTON, Mass., March 20, 2023 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings, today reported its financial results for the year ended December 31, 2022. “Significant developmental strides were made during 2022, with our IL-6 clinical study data affirming the potential of Bluejay’s Symphony System to be a rapid and precise testing platform for near-patient management in critical care settings,” said Neil Dey, CEO of Bluejay Diagnostics. “Recent positive feedback from the FDA indicated an expansion of our clinical study would be necessary to support our planned de novo submission, extending our anticipated submission timeline to the first half...

Eterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights

Written by Customer Service on March 20, 2023. Posted in Earnings Releases And Operating Results.

– Executed income generating license agreement with Lineage Cell Therapeutics to develop gene-edited induced pluripotent stem cell (iPSC)-derived therapies for multiple neurology indications – Entered into a sublease agreement with Bristol Myers Squibb to occupy 45,000 sq. ft. of lab and office space at Cambridge Crossing development in Cambridge, Massachusetts – Appointed Matt Angel, Ph.D. as Chief Executive Officer and President CAMBRIDGE, Mass., March 20, 2023 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced financial results for the quarter and year ended December 31, 2022 and provided a business update. “2022 was a transformational...

Canterbury Park Holding Corporation Reports 2022 Fourth Quarter Results

Written by Customer Service on March 20, 2023. Posted in Earnings Releases And Operating Results.

SHAKOPEE, Minn., March 20, 2023 (GLOBE NEWSWIRE) — Canterbury Park Holding Corporation (“Canterbury” or the “Company”) (NASDAQ: CPHC), today reported financial results for the fourth quarter and full year ended December 31, 2022. ($ in thousands, except per share data and percentages) Three Months Ended December 31, Twelve Months Ended December 31, 2022 2021 Change(3) 2022 2021 Change Net revenues(2) $13,119 $13,955 -6.0% $66,824 $60,400 10.6% Net income(2) $1,063 $6,620 -83.9% $7,513 $11,798 -36.3% Adjusted EBITDA(3) $2,687 $3,360 -20.0% $15,141 $13,471 12.4% Basic EPS $0.22 $1.38 -84.1% $1.55 $2.47 -37.2% Diluted EPS $0.22 $1.37 -83.9% $1.54 $2.44 -36.9%(1) Financial...

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

Written by Customer Service on March 20, 2023. Posted in Earnings Releases And Operating Results.

Record AVISE® CTD Volume in 2022 SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent Highlights:Record 135,210 flagship AVISE® CTD tests, for the full year 2022, including 33,819 tests for the fourth quarter of 2022. Since the launch of AVISE® CTD in 2012, we have now delivered approximately 750,000 of these tests. Total revenue of $45.6 million for the year ended December 31, 2022, and total revenue of $12.8 million for the fourth quarter of 2022. John Aballi, President and CEO, joined the Company in the fourth quarter of 2022 and implemented a new strategy focused on reducing cash burn and driving ASP and GM improvement to ultimately reach profitability...

CERBERUS CYBER SENTINEL ANNOUNCES PRELIMINARY ESTIMATED FINANCIAL INFORMATION

Written by Customer Service on March 20, 2023. Posted in Earnings Releases And Operating Results.

Receives $5.0 million from private convertible note offering Scottsdale, Ariz., March 20, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Cerberus Cyber Sentinel Corporation (“Cerberus Sentinel” or the “Company”) (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, based in Scottsdale, Ariz., today announced certain preliminary estimated financial information as of and for the quarter and fiscal year ended December 31, 2022. The preliminary estimated financial information has been prepared by, and is the responsibility of, the Company’s management. Semple, Marchal & Cooper, LLP, the Company’s independent registered public accounting firm, has not audited, reviewed, compiled or performed any procedures with respect to the preliminary estimated financial information provided below. The Company’s...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals